Health
New Alzheimer’s drug aducanumab is dividing doctors and patients, as the TGA weighs up its risk-benefit profile – ABC News
The first new Alzheimer’s drug approved by US regulators in almost two decades is generating global interest and global controversy….
After a decades-long career as a biology teacher, John Rodgers applies the strict logic of a scientist to answer tough questions.
So, when it comes to his mortality, he is equally rational.
“I either want it to end quickly or get better,” he said.
Key points:
…
Continue Reading
-
Business21 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News17 hours agoTips to improve engagement – Proctor
-
Noosa News20 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General15 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline